ConductScience.org, home

Library / Trials

Compensatory Brain Activity in Older Adults.

NCT06235840, Not applicable, Completed, Kazimierz Wielki University

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleCompensatory Brain Activity in Older Adults.ClinicalTrials.gov
NCT numberNCT06235840ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment117 participants, actualClinicalTrials.gov
Lead sponsorKazimierz Wielki UniversityClinicalTrials.gov
ConditionsOld Age; Dementia, Aging, Cognitive DeclineClinicalTrials.gov
Interventionsworking memory adaptive training, multi-domain non-adaptive control trainingClinicalTrials.gov
First posted2024-02-01ClinicalTrials.gov
Last updated2024-02-01ClinicalTrials.gov

Registered outcomes 14

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryChange EEG power in theta, alpha and gamma bands (n-back task)change from baseline at 4 weeks
The neural brain activity accompanying cognitive engagement during the n-back task execution. EEG data will be obtained from 32 Ag/AgCl electrodes (left: Fp1, AF3, F3, F7, FC1, FC5, C3, CP1, CP5, F7, P3, P7, PO3, O1; right: Fp2, AF4, F4, F8, FC2, FC6, C4, CP2, CP6, F8, P4, P8, PO4, O2; midline: Fz, Cz, Pz, Oz) placed in accordance with the 10-20 international system and referenced to the right and left earlobes.
ClinicalTrials.gov
PrimaryChange n-back taskchange from baseline at 4 weeksAccuracy and reaction times in the n-back task indicated by the senstitivity indexClinicalTrials.gov
PrimaryChange in EEG power in theta, alpha and gamma bands (GoNoGo task)change from baseline at 4 weeks
The neural brain activity accompanying cognitive engagement during the GoNoGo task execution. EEG data will be obtained from 32 Ag/AgCl electrodes (left: Fp1, AF3, F3, F7, FC1, FC5, C3, CP1, CP5, F7, P3, P7, PO3, O1; right: Fp2, AF4, F4, F8, FC2, FC6, C4, CP2, CP6, F8, P4, P8, PO4, O2; midline: Fz, Cz, Pz, Oz) placed in accordance with the 10-20 international system and referenced to the right and left earlobes.
ClinicalTrials.gov
PrimaryChange in GoNoGo taskchange from baseline at 4 weeksAccuracy and reaction times in the GoNoGo task.ClinicalTrials.gov
PrimaryChange in EEG power in theta, alpha and gamma bands (Stroop task)change from baseline at 4 weeks
The neural brain activity accompanying cognitive engagement during the Stroop task execution. EEG data will be obtained from 32 Ag/AgCl electrodes (left: Fp1, AF3, F3, F7, FC1, FC5, C3, CP1, CP5, F7, P3, P7, PO3, O1; right: Fp2, AF4, F4, F8, FC2, FC6, C4, CP2, CP6, F8, P4, P8, PO4, O2; midline: Fz, Cz, Pz, Oz) placed in accordance with the 10-20 international system and referenced to the right and left earlobes.
ClinicalTrials.gov
PrimaryChange in Stroop taskchange from baseline at 4 weeksAccuracy and reaction times in the Stroop taskClinicalTrials.gov
PrimaryChange in OSpan taskchange from baseline at 4 weeksAccuracy in the OSpan taskClinicalTrials.gov
SecondaryChange in Digit Spanchange from baseline at 4 weeksThe Digit Span Subtest from the Wechsler Adult Intelligence Scale - WAIS-R (PL)ClinicalTrials.gov
SecondaryChange in Digit-Symbolchange from baseline at 4 weeksThe Digit-Symbol Coding Subtest from the Wechsler Adult Intelligence Scale - WAIS-R (PL)ClinicalTrials.gov
SecondaryChange in Raven's SPMchange from baseline at 4 weeks
Raven's Standard Progressive Matrices: Classic form in Polish standardisation / Parallel form n Polish standardization. minimum and maximum values (raw score): 0-60, higher scores mean a better outcome
ClinicalTrials.gov
OtherM.I.N.I. Screen 7.0.2On the first day of participation in the study, successively for the following participants over 3 yearsA structured diagnostic interview - Mini International Neuropsychiatric Interview - The M.I.N.I. Screen 7.0.2. - to screen for the presence of psychiatric disordersClinicalTrials.gov
OtherStructured interviewOn the first day of participation in the study, successively for the following participants over 3 years• A structured interview, constructed for the purpose of the study: to gather information about age, neurodegenerative diseases, severe head injuries, vision defectsClinicalTrials.gov
OtherMMSEOn the 1st day of participation in the study of each older adult, successively for the following participants over 3 yearsMini Mental State Examination - MMSE: to screen for dementia in older adults; the minimum and maximum values: 0-30, higher scores mean a better outcomeClinicalTrials.gov
OtherACE IIIOn the 1st day of participation in the study of each older adult, successively for the following participants over 3 years• The Addenbrooke's Cognitive Examination III - ACE III: to screen for the presence of cognitive impairment in older adults; minimum and maximum values: 0-100, higher scores mean a better outcomeClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
38943197DERIVEDPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 7

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
1-Back TaskPrimary outcomeConductCognition
2-Back TaskPrimary outcomeConductCognition
Operation SpanPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition
Digit Span TestSecondary outcomeConductCognition
Matrix ReasoningSecondary outcomeConductCognition
Symbol CodingSecondary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)